Treated CLL patients displayed simultaneously increased expression of CD64 (P < 0.001), higher percentage of CD64 (P < 0.05) and CD54 (P < 0.01) compared to untreated patients. This evidence concerns the gene FCGR1A and B-cell chronic lymphocytic leukemia.